Gregory Korbel

Direttore operativo presso Atrin Pharmaceuticals, Inc.

48 anni

Health Technology

Consumer Services

Posizioni attive di Gregory Korbel

Società	Posizione	Inizio	Fine
Atrin Pharmaceuticals, Inc. Atrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Founded in 2012, Atrin Pharmaceuticals, Inc. is a DNA Damage Response development company that focuses on a pipeline of products resulting from a series of novel conformationally restricted macrocyclic molecules. Part of Aprea Therapeutics, Inc., the company is based in Doylestown, PA. Atrin Pharmaceuticals was acquired by Aprea Therapeutics, Inc. on May 16, 2022 for $1.33 million. The company's products have the highest known potency for inhibiting ATR and exhibit ATR selectivity with potential broad therapeutic profile.	Direttore operativo	-	-

Società	Posizione	Inizio	Fine
APREA THERAPEUTICS, INC.	Direttore operativo	01/05/2022	31/03/2023
APREA THERAPEUTICS, INC.	Corporate Officer/Principal	01/07/2016	01/05/2022
Novira Therapeutics LLC Novira Therapeutics LLC Pharmaceuticals: MajorHealth Technology Novira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the discovery and development of therapies for the treatment of chronic hepatitis B (CHB) infection. The firm’s novel antiviral drug candidates addresses the limitations of CHB therapies. The company was founded in 2009 by Osvaldo Flores, Ali Munawar and George D. Hartman and is headquartered in Doylestown, PA.	Direttore operativo	01/08/2012	01/12/2015
JOHNSON & JOHNSON	Corporate Officer/Principal	-	-

Vanderbilt University	Undergraduate Degree
Harvard University	Doctorate Degree
The Wharton School of the University of Pennsylvania	Masters Business Admin

Distribuzione geografica

Stati Uniti

Posizioni

Chief Operating Officer	3
Corporate Officer/Principal	2
Undergraduate Degree	1

Settori

Health Technology	5
Consumer Services	4

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	2
APREA THERAPEUTICS, INC.	Health Technology
JOHNSON & JOHNSON	Health Technology

Aziende private	2
Novira Therapeutics LLC Novira Therapeutics LLC Pharmaceuticals: MajorHealth Technology Novira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the discovery and development of therapies for the treatment of chronic hepatitis B (CHB) infection. The firm’s novel antiviral drug candidates addresses the limitations of CHB therapies. The company was founded in 2009 by Osvaldo Flores, Ali Munawar and George D. Hartman and is headquartered in Doylestown, PA.	Health Technology
Atrin Pharmaceuticals, Inc. Atrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Founded in 2012, Atrin Pharmaceuticals, Inc. is a DNA Damage Response development company that focuses on a pipeline of products resulting from a series of novel conformationally restricted macrocyclic molecules. Part of Aprea Therapeutics, Inc., the company is based in Doylestown, PA. Atrin Pharmaceuticals was acquired by Aprea Therapeutics, Inc. on May 16, 2022 for $1.33 million. The company's products have the highest known potency for inhibiting ATR and exhibit ATR selectivity with potential broad therapeutic profile.	Health Technology

Aziende private

Health Technology